Social support for the chronically ill during lockdown. Qualitative research in the COVID‐19 pandemic
Chronic illness requires a web of actors, both professional and familiar, who constitute the support network of the chronically ill. This article aims to analyse how the COVID-19 pandemic has impacted on the delicate balance of these supports. Qualitative research was conducted among people with four types of chronic diseases in France: cystic fibrosis, kidney disease, haemophilia and mental disorders. Data on social support was collected using an innovative methodology combining semi-directive interviews (n = 54) and drawings (n = 32). During the first French lockdown (March-May 2020), the chronically ill were mainly supported by the usual support actors of their primary network: spouse and/or family. However, the COVID-19 health crisis has led to several changes in their support network; health-care professionals diversified their support roles and new supporting actors emerged, especially non-human entities and patient organisations. The chronically ill have received an interweaving of emotional, instrumental and informational, formal and informal and human and non-human support. Our study highlights the multiple and dynamic ties between these types of support and argues in favour of a comprehensive approach to social support of the chronically ill, both in social science theory and in practice of care.
Authors
- Élise Ricadat (ORCID: https://orcid.org/0000-0001-8202-1523)
- Céline Gabarro (ORCID: https://orcid.org/0000-0002-9312-2060)
- Louise Virole (ORCID: https://orcid.org/0000-0002-3782-181X)
Institutions
- Université Paris Cité (FR)
- Université de Lille (FR)
- Sorbonne Paris Cité (FR)
- Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société (FR)
Publication Details
- Journal
- Sociology of Health & Illness
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1111/1467-9566.13845
- Citations
- 2
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Agence Nationale de la Recherche